Also listed on Axelia Oncology Pty Ltd., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Sep 22, 2031 · Low confidence
20-year base term ends Sep 22, 2031
Sep 22, 2011
Sep 22, 2031
Oct 17, 2023
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 1 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 22, 2011, when application PCT/AU2011/001225, the earliest non-provisional in its chain, was filed (this one was filed May 24, 2022); a parent in its chain could not be resolved (the next row) | Sep 22, 2031 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,406,100) | resolves to Sep 22, 2031, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 15596427, 15596427 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Sep 22, 2031 | Low confidence |
Partial family
| Application PCT/AU2011/001225 | PCT application no patent term | no patent term |
| US 9,676,819 | In force Oct 2031 | Oct 2031 |
| US 10,406,100 | In force Sep 2031 | Sep 2031 |
| US 11,351,114 | In force Sep 2031 | Sep 2031 |
| US 11,786,458 | this patent Sep 2031 | Sep 2031 |
| US 12,569,431 | In force Sep 2031 | Sep 2031 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 31, 2022 Reel 60949, frame 760 | Ena Therapeutics Pty Ltd. | Axelia Oncology Pty Ltd. | Change of Name |
| Sep 2, 2022 Reel 60974, frame 801 | Axelia Oncology Pty Ltd. | Ena Respiratory Pty Ltd. | Assignment of Assignor's Interest |
| Aug 22, 2023 Reel 64662, frame 815 | Jackson, David Charles; Tan, Amabel; Zeng, Weiguang | The University of Melbourne | Assignment of Assignor's Interest |
| Aug 22, 2023 Reel 64663, frame 277 | Innavac Pty Ltd. | Ena Therapeutics Pty Ltd. | Change of Name |
| Aug 22, 2023 Reel 64663, frame 691 | The University of Melbourne | Innavac Pty Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,406,100, ends no earlier than this term, so it caps nothing.